What's Happening?
A systematic review published in Nutrients has confirmed the safety of human milk oligosaccharides (HMOs) across 26 clinical trials involving various populations, including adults, children, and infants. The trials consistently found that HMO supplementation
was safe and well-tolerated, with side effects such as mild gastrointestinal symptoms being comparable to placebo. HMOs have also received regulatory approval in the US and EU, including GRAS status and Novel Food approval.
Why It's Important?
The consistent safety findings across multiple trials reinforce the potential of HMOs as a safe dietary supplement for a wide range of populations. This could lead to increased consumer confidence and demand for HMO-based products, particularly in the gut health and infant nutrition markets. The regulatory approvals further support the integration of HMOs into food and supplement products, potentially driving innovation and growth in these sectors.
